Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →In 777 childhood cancer survivors from four European countries, self-reported low physical activity, smoking, alcohol consumption, and drug use were prevalent to varying degrees and were associated with factors including sex, education, reduced physical health, pain, and fatigue.
The evidence identifies associations rather than treatment effects; it supports the hypothesis that country- and risk-tailored lifestyle interventions, potentially incorporating management of pain, fatigue, and reduced physical health, could improve health behaviours in childhood cancer survivors, but this requires prospective interventional testing.
In a retrospective cohort of 21 children with refractory inflammatory bowel disease, combined anti-TNF-α and vedolizumab therapy was associated with increased steroid-free clinical, endoscopic, and histological remission, but two significant infections occurred.
The record supports dual anti-TNF-α–vedolizumab therapy as a possible option for refractory pediatric inflammatory bowel disease; any relevance to pediatric cancer treatment or oncology-associated intestinal inflammation is untested inference and is not established by this study.
In a retrospective single-center cohort of 81 fetuses with cardiac tumors, tumor multiplicity was associated with tuberous sclerosis complex, MRI increased prenatal TSC detection over ultrasound alone, and postnatal outcomes varied by tumor type, hemodynamic effects, and TSC status.
The evidence supports prenatal imaging, genetic evaluation, and tumor phenotyping for risk stratification; it can be inferred—but is not tested here—that an algorithm incorporating tumor type, multiplicity, location, volume, and TSC status could improve surveillance and selection for intervention while avoiding unnecessary treatment of regressing rhabdomyomas.
In a retrospective national surgical-database analysis of 2,260 pediatric nephrectomies for malignant renal tumors, lymph node sampling occurred in 72.1%, differed by surgical specialty and disease extent, and did not significantly improve after the 2018 educational campaign.
The evidence identifies persistent underuse of recommended lymph node sampling but does not test an intervention or demonstrate improved cancer outcomes; it is reasonable to hypothesize that operative checklists, sampling maps, and multidisciplinary quality-improvement programs could increase sampling and thereby improve staging-dependent treatment selection, but this requires prospective evaluation.
This systematic review identified 26 pediatric endoscopic spine surgery studies involving 1,023 patients, predominantly treated for lumbar disc herniation, while oncologic applications were limited to reports of two bone-lesion excisions and the overall evidence was nonrandomized and at substantial risk of bias.
Evidence: pediatric endoscopic spine procedures have reported favorable outcomes mainly for lumbar disc herniation, whereas tumor-related experience is confined to isolated bone-lesion excisions. Inference: minimally invasive endoscopic approaches might eventually reduce surgical morbidity in selected pediatric spinal lesions, but the supplied record does not establish oncologic efficacy, safety, appropriate selection criteria, or equivalence to standard tumor surgery.
This single-center retrospective Pakistani cohort reports presentation, surgical management, and short-term outcomes for 19 children with primary spinal cord tumors, finding that resection was feasible but that diagnostic delays, incomplete data, and limited follow-up constrained outcome assessment.
Evidence: surgery was feasible in this resource-constrained cohort, with limited documented perioperative morbidity and neurological improvement or stability in 10 of 12 children with available follow-up. Inference: earlier diagnosis and more standardized multidisciplinary, surveillance, rehabilitation, infection-prevention, and adjuvant-therapy pathways might improve outcomes, but this study does not test those interventions or establish comparative benefit.
In a single-center retrospective propensity score-matched cohort, spontaneous hepatoblastoma rupture was associated with larger tumors, advanced local disease, macrovascular invasion, and worse overall and event-free survival in children.
The study provides observational evidence that tumor size and macrovascular invasion may flag children at elevated risk of spontaneous rupture; it is an untested inference that using these features for intensified surveillance or earlier multidisciplinary planning could prevent rupture-related complications or improve outcomes.
In a prospective US multi-institutional registry, 88 adults with nonmetastatic hepatocellular carcinoma treated with definitive proton beam therapy had an estimated 2-year freedom from local failure of 93.4%, overall survival of 54.9%, and no reported grade 3 or higher toxicity.
The registry supports an association between dose-escalated, predominantly moderately hypofractionated proton therapy and favorable local control with low reported severe toxicity; it is inferential—not demonstrated comparatively—that proton dosimetry could improve the therapeutic ratio, particularly for large tumors, and the record provides no evidence for pediatric patients.
A FAERS disproportionality analysis of 2,421 reports naming doxorubicin as the primary suspect identified expected cardiac toxicity signals and a potentially novel signal for vascular endothelial dysfunction, with reports arising predominantly from adults.
The record supports a pharmacovigilance association between doxorubicin and reported endothelial dysfunction; it remains an inference, requiring pediatric-specific validation, that vascular monitoring or endothelial-protective strategies could improve toxicity detection or prevention.
In a two-institution retrospective series of nine children undergoing vascularized fibular epiphyseal transfer after tumor resection, graft hypertrophy and occasional neo-joint remodeling were observed, but growth was unpredictable and mechanical complications were frequent.
The reported clinical evidence suggests that VFET can provide a living reconstruction with hypertrophy and some remodeling potential after pediatric oncologic resection; inferentially, improved patient selection, growth surveillance, fixation, and non-union prevention might preserve this benefit while reducing the high mechanical complication burden, but the record does not establish these strategies or comparative superiority.
This case-based report describes a 30-day songwriting process within medical music therapy for a 12-year-old with advanced Burkitt lymphoma, reporting support for emotional expression, communication, meaning-making, and family emotional continuity near the end of life.
The reported case suggests that songwriting may serve as a flexible supportive-care intervention for emotional expression and family-centered meaning-making in pediatric palliative oncology; whether it reliably improves distress, communication, quality of life, or bereavement outcomes remains an untested inference.
In baseline cross-sectional data from 83 children aged 1–5 years newly diagnosed with cancer, most showed below-average gross motor function, mobility, and handgrip strength relative to age-expected normative values, while some physical-performance and strength assessments had limited feasibility.
The study provides evidence that functional impairments are already present near cancer diagnosis in many preschool children; it is reasonable—but not tested here—to hypothesize that early, developmentally tailored physical rehabilitation could preserve or improve motor function, mobility, and strength during treatment.
